JOHNSON & JOHNSON Long-Term Concentrated

Location: New Brunswick, NJ

CIK: 0000200406 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 9, 2023

Total Value: $271M (100.0% shares, 0.0% debt)

Holdings (24)

LEGN Legend Biotech Corporation 20.2%
Value $54.72M Shares 814,586 Est. Cost $50.56 Unrealized
CVRX CVRx, Inc. 19.5%
Value $53.03M Shares 3,495,575 Est. Cost $19.18 Unrealized -14.2%
PTGX Protagonist Therapeutics Inc. 15.0%
Value $40.85M Shares 2,449,183 Est. Cost $42.63 Unrealized -54.5%
MGTX MeiraGTx Holdings plc 12.0%
Value $32.61M Shares 6,641,064 Est. Cost $9.84 Unrealized -38.3%
XNCR Xencor, Inc. 5.6%
Value $15.07M Shares 748,062 Est. Cost $37.91 Unrealized -40.0%
NMRA Neumora Therapeutics, Inc. 4.7%
Value $12.87M Shares 912,128 Est. Cost $12.87 Unrealized 0.0%
PRCT Procept BioRobotics Corporation 4.3%
Value $11.74M Shares 357,939 Est. Cost $38.38 Unrealized -11.2%
Fusion Pharmaceuticals Inc. 3.5%
Value $9.543M Shares 3,670,516 Est. Cost $7.92 Unrealized
NBTX Nanobiotix S.A. 3.1%
Value $8.397M Shares 959,637 Est. Cost $8.75 Unrealized
FATE Fate Therapeutics, Inc. 2.6%
Value $7.164M Shares 3,379,064 Est. Cost $78.44 Unrealized -95.8%
Point Biopharma Global Inc. 2.5%
Value $6.67M Shares 1,000,000 Est. Cost $7.69 Unrealized
ARWR Arrowhead Pharmaceuticals, Inc. 2.5%
Value $6.653M Shares 247,598 Est. Cost $64.75 Unrealized -52.7%
ALDX Aldeyra Therapeutics, Inc. 1.0%
Value $2.637M Shares 394,834 Est. Cost $9.18 Unrealized -19.2%
HLTHQ Cue Health, Inc. 0.9%
Value $2.454M Shares 5,548,864 Est. Cost $11.81 Unrealized
Vor Biopharma, Inc. 0.8%
Value $2.278M Shares 1,074,658 Est. Cost $15.68 Unrealized
NNOX Nano-X Imaging Ltd. 0.8%
Value $2.084M Shares 317,704 Est. Cost $15.61 Unrealized -34.1%
Adicet Bio, Inc. 0.4%
Value $999K Shares 728,944 Est. Cost $7.84 Unrealized
BiomX Inc. 0.3%
Value $751K Shares 2,133,402 Est. Cost $3.06 Unrealized
SomaLogic, Inc. 0.2%
Value $672K Shares 281,052 Est. Cost $12.39 Unrealized
Clearside Biomedical, Inc. 0.1%
Value $148K Shares 169,629 Est. Cost $1.12 Unrealized
Apollomics, Inc. 0.0%
Value $49,629 Shares 13,252 Est. Cost $24.20 Unrealized
Senseonics Holdings, Inc. 0.0%
Value $32,986 Shares 54,621 Est. Cost $3.39 Unrealized
Catalyst Biosciences, Inc. 0.0%
Value $32,290 Shares 66,951 Est. Cost $4.11 Unrealized
Tracon Pharmaceuticals, Inc. 0.0%
Value $14,953 Shares 84,003 Est. Cost $3.87 Unrealized